Between Epidemiology and Basic Genetic Research – Systems Epidemiology by Eiliv Lund
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
5 
Between Epidemiology and Basic Genetic 
Research – Systems Epidemiology 
Eiliv Lund 
University of Tromsø 
Norway 
1. Introduction 
Systems epidemiology can be considered as an attempt to implement functional genomic 
analyses into the common prospective design. Functional genomics cover research on genes, 
genomes and the products of genes such as gene transcripts (mRNA and microRNA) and 
proteins. Methods include gathering, integrating, and analyzing complex data from high 
throughput technologies such as genomics, epigenomics, transcriptomics, proteomics, and 
metabolomics (often collectively named “the ‘omics”). A main goal is to build models to 
better understand the complex interactions taking place within cells, tissues or whole 
organisms, using mathematical, statistical and computational approaches. Some of these 
high throughput techniques can be run in available material, some need new biological 
sampling. The expansion of the information available through these methods has created a 
challenge for the analyses both in terms of laboratory analyses, statistical analyses and 
functional interpretations. At the same time it will mirror the current dichotomy in research 
between epidemiology and basic research. The goal of this chapter is to point to the 
alternative research direction of functional genomics created by the new technological 
opportunities. The time should have come for including functional measures in both blood 
and tissues in prospective observations studies of humans. With this as a background the 
design and current analytical approaches of the Norwegian Women and Cancer 
postgenome cohort will be discussed in relation to carcinogenesis. The chapter will deal 
more with study design and related aspects than with statistics or biology.  
2. Background 
Modern technology has over the last decade given epidemiologists the opportunity for 
expanding their field of science from the studies of associations between exposures and 
disease till gene-environment analyses of single nucleotide polymorphisms, SNPs, as part of 
molecular epidemiology (1). The genome wide association studies, GWAS, created both the 
need for huge collaborative efforts, high throughput technologies and novel statistical 
approaches due to the large number of comparisons done. One example of the collaborative 
efforts could be the Consortium of cohorts (2), and the adjustment of p-values to keep an 
adequate false discovery rate is an example of novel statistical methods for the GWAS 
analyses (3). As part of the gene-environment exploration the scientific approach has 
changed from single gene analyses based on biological knowledge of the function till 
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inductive or hypothesis generating approaches by looking at all genes simultaneously (1). 
This is also named the agnostic approach (4). So far the GWAS studies in cancer have 
discovered around 200 SNPs that most have a relative risk less than two. The post-GWAS 
strategy is under discussion, and the direction recommended is towards studies of 
functional aspects of these SNPs (4).  
This development should be held against the common view behind the agnostic GWAS 
strategy which strongly points to the lack of exact biological information for making exact 
single genes or pathways approaches fruitful. In fact, the lack of in vivo derived information 
on most genes and pathways as part of carcinogenesis could hamper the search for 
mechanisms of carcinogenesis. 
Another approach to expand the field of traditional epidemiology is systems epidemiology 
(5). This scientific discipline is the equivalent of systems biology, but performed in an 
epidemiological scale. In systems biology, high throughput ‘omics‘ technologies are 
combined with computational analyses to investigate the metabolism of cells, tissues or 
organisms during health and disease. The aim of systems epidemiology is to study 
molecular mechanisms of disease in epidemiological studies. Systems epidemiology 
implicate better collections of biological material for functional studies and a carcinogenic 
model more relevant for epidemiology – an exposure driven functional model (6). 
3. Status of functional genomics in epidemiology 
The extent to which systems epidemiology is a realistic approach depends on the 
underlying assumption that blood and tissues communicate through gene expression and 
that the communication from cells undergoing a disease process through the blood might be 
trace signals from distorted metabolic pathways. This approach depends on adequately 
collected and stored biological material suitable for high throughput technologies used for 
studies of functional changes during the development of chronic diseases. Transcriptomics 
consists of two major classes of gene expression functions. mRNA is a copy or a messenger 
of the gene code information stored as DNA for the production of proteins in the cell. It is 
rapidly degraded by the Rnase. microRNAs are not coding for proteins, but regulates the 
expression of mRNAs. It is more resistance to degradation and can be used as biomarkers 
(7). New studies of the transport and delivery of microRNA are rapidly growing, strongly 
supporting the view that blood is an important channel for communication between cells. 
Thus, the basic assumption of systems epidemiology gains momentum. 
The extent to which mRNA and microRNA are transported in the blood stream as 
information carriers can only be verified in humans through a prospective study design. 
There exist many studies with repeated blood samples with DNA from plasma/serum, but 
few with biological material suitable for gene expression analyses of mRNA simultaneously 
of peripheral blood and tumour tissue. One serious objection is the time frame for the 
function of gene expression which could differ, so the snapshot through one blood sample 
could give a confusing picture. But, those important cell regulations that are disturbed in the 
disease process should be expected to have some constancy over time since most exert the 
effects as a consequence of substantial exposures over a prolonged time. The success of this 
approach could depend on repeated measurements in order to be able to study changes in 
gene functions over a lifetime.  
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There is growing evidence that gene expression in peripheral blood reflects different 
lifestyle factors. Several cross-sectional studies of gene expression have been published 
highlighting numerous and interconnected pathways or gene sets affected in blood by 
defined lifestyle factors or exposure variables e.g. smoking (8), hormones (9) or organic 
pollutants (10). Important objections are the level of technical noise (11). Although blood 
gene expression profiling promises molecular-level insight into disease mechanisms, there 
remains a lack of baseline data describing the nature and extent of variability in blood gene 
expression in the general population. Characterizations of this variation and the underlying 
factors that most influence gene expression amongst healthy individuals play an important 
role in the feasibility, design and analysis of future blood-based studies. The number of 
studies with lifestyle exposures related to microRNA is absent and only a few studies exist 
for epigenetics “e.g”. DNA methylation (12). In addition, a few case-control studies (13) 
have been published. So far these cross-sectional studies have not been transformed into 
prospective studies. At the same time a large number of studies have been publish based on 
clinical cohorts relating gene expression patterns in tumour tissue to survival and prognosis. 
Several studies have shown the usefulness of more functional classification of breast cancer 
(14). This might be important for etiological research as a means to improve the 
classification of breast cancer tumours. 
4. An example of a biological model and the relationship to epidemiology: 
The two-stage model of carcinogenesis 
In cancer epidemiology, the estimations of the carcinogenic multistage model is more than 
fifty years old (15). The situation today is not different from the early papers, namely that 
there is a lack of observational data of the stages of carcinogenesis. Due to this lack of 
observed data the parameters in the mathematical model can not be solved uniquely (16). At 
the same time the importance of fixing one parameter in the mathematical model has been 
stressed, this could be the duration or changes related to the last stage. There exist at least 
five models (15), some of them clearly more explored than others like the two-stage clonal 
growth model (17), figure 1. 
The biological model considers that the carcinogenic process starts with a mutation which is 
a change in one of the DNA sequences of a gene. The cell with this mutation then will 
undergo a rapid growth named the clonal phase. A second mutation will be necessary in 
order to have a transformed cancer cell that will grow as a tumour through the promotional, 
last stage. Dependent on the exposure which drives the carcinogenic process a stop or 
withdrawal of exposure could bring the promotional stage into arrest or the cancer cells 
could die through a process named apoptosis. 
5. The functional genomics of prospective studies – The globolomic design 
The structure of a globolomic study design could be as shown in figure 2. On the left 
different sources of exposure information are given, from questionnaires, blood samples, 
tissue samples and pathological paraffin blocks. The differences between the traditional 
cohort study and the globolomic one is given at the right side of the figure 2. The richness of 
biological material multiplies the possible analytical strategies, at the same time the 
complexity is far beyond current epidemiological methodology.  
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Fig. 1. Schematic description of the relationship between the clonal two-stage model and 
different scenarios of exposures.  
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Fig. 2. The globolomic prospective study design. 
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As an example of the need for new and extended collection of both biological material and 
questionnaire information is given the structure of the Norwegian Women and Cancer 
cohort in Box 1, for more detailed information see (18).  
1. Women sampled at random from the Norwegian population register, 172 000 women 
were enrolled.  
2. Mailed letter of invitation and a questionnaire.  
3. The postgenome biobank. Women born 1943-57 were eligible since they were invited 
or would be invited to participate in the Norwegian national mammographic 
screening program covering women 50-69 years, altogether 148 000.  
4. Women were asked if they were willing to donate a blood sample to the study and 
at the same time give consent to update information on place of living. 
Approximately 95% of those returning the eight pages questionnaire answered yes 
to both questions. 
5. Blood sampling. A package containing equipment for blood sampling and a two-
paged questionnaire were mailed by groups of 500 random women. Participants 
brought the blood collection kit to their physicians office for blood sampling; one 
standard citrate tube and one collection tube containing a buffer for preservation of 
mRNA and microRNA. The blood samples give us access to mRNA and microRNA 
for gene expression, DNA from “buffy coat” for SNPs analyses, plasma for studies of 
metabolomics and proteomics.  
6. The passive follow-up was completed through linkage to the national cancer registry in 
Norway based on the unique birth number and to registers of death and emigration. 
The information on cancer can then be used as end-points.  
7. Collection of tumour biopsies through an active follow-up of all 148 000 women born 
1943-57 at the time of diagnosis in collaboration with 10 of the major hospitals 
throughout Norway covered around 40% of the study sample. When a woman 
presented at the hospital with a lump in her breast, or one was diagnosed at the 
mammographic screening unit, all women were asked if they had participated in the 
NOWAC study. If they answered yes they were asked to give informed consent for a 
second biopsy for research use. At the same time they gave a blood sample and filled 
in a one page questionnaire.  
8. For each of these women five random controls were drawn from the NOWAC 
postgenome cohort matched by age and date of the original blood donation. From 
these blood samples the same information can be extracted as from those blood 
samples collected originally. From the biopsy one can obtain microRNA, mRNA and 
tumour DNA.  
9. For all cases of breast cancer the paraffin blocks stored in the pathological bio-banks 
are searched for to obtain microRNA and DNA.  
10. Collection of breast tissue biopsies from healthy women participating in the 
NOWAC study and living in the north of Norway.  
Box 1. Design, approaches and content of the Norwegian Women and Cancer postgenome 
study. 
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6. Challenges of systems epidemiology 
The following will discuss several challenges raised by the introduction of functional 
genomics in prospective studies as part of systems epidemiology. The total amount of 
information is challenging the ordinary epidemiological analytical systems. From the 
DNA one can extract information for 500 000 SNPs, the same from tumour DNA, for each 
of the blood samples there will be a unique set of 25 000 gene expressions of mRNA and 
around 1 000 microRNAs. The methylation chips for epigenetic analyses cover around 
500 000 variants. The number of measurements of metabolomics could be tens till 
hundreds. The proteomic screening analyses is just underway. Lastly, the questionnaire 
information could cover around 1 000 variables. In addition, there are scanned pictures 
from the microarrays and many files with technical information. Altogether, the storing 
and use of such large data sets will be dependent on computer science and cluster 
computers. 
6.1 The nature of gene expression as exposure variable 
In a prospective study gene expression could be classified as exposure. In a traditional 
design one would then use a Cox proportional model to estimate the relative hazard. This 
has typically been the procedure with the GWAS studies of SNPs. A SNP is a lifelong lasting 
characteristic that does not change over time or during follow-up. As such, SNPs could look 
as an ideal exposure variable being reliable and constant over the follow-up time. The 
analyses of gene expression in a follow-up study will be complicated by the possibilities of 
different population distributions throughout the follow-up period of the differences 
between cases and controls for each of the single of the 25 000 genes. Suppose we expect the 
gene expression in the controls to be similar over time. The hypothesis for a mutagen could 
be that the gene expression in the cases changes during follow-up as a consequence of 
events related to the disease process. We would then search for a change in the distribution 
of the differences in gene expression between cases and controls. These differences could 
have many potential distributions. The proportional hazard function would not be 
adequate.  
The novel design gives us several challenges: 
Challenge one: Biologically, the gene expression measured as the difference between the 
cases and the controls could either be the consequence of the exposure i.e. smoking changes 
the expression of a large number of genes, or the ongoing carcinogenic process due to the 
same exposures. This raises some methodological and statistical problems; how to estimate 
the changes in gene expression due to the carcinogenic process independently of the 
changes due to the carcinogen not necessarily linked to the carcinogenic process. If a 
mutation took place then the exponential increase in cancer cells could give a similar 
increase in expression of the affected genes. The differences in gene expression would then 
be an exponential function over time. Just putting both the gene expression variables and 
the exposure variables into the same model could give an unmeasured over adjustment of 
some of these variables. This can be handled by stratification which on the other hand 
would decrease the statistical power. Again, the analyses should be run agnostic before the 
information from basic research on gene function should be used.  
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Challenge two: As mentioned the traditional GWAS studies have been based mainly on the 
Cox proportional hazard model or using logistic regression analyses. The use of 
proportional hazard has the assumptions of proportionality and multiplicative risk 
estimation. There is no basic or epidemiological evidence of proportional hazard over time 
for the gene expression. In contrast, several other time-dependant models could be used. 
The null hypothesis of no differences over time between the gene expression of cases and 
controls would in a linear model be closely parallel lines, eventually with the same beta-
coeffisient. 
One plausible model could be an increasing level of gene expression in cases compared to 
the controls as an effect of the mutations giving a clonal growth. This would give an 
exponential curve in an additive model or a straight line in a logarithmic model. There are 
many potential models that should be explored, but at the moment no strong preferences for 
the models exists from observational studies.  
Challenge three: In traditional epidemiology including the gene-environment analyses of 
GWAS the search has been for the highest relative risks or the lowest p-values. This simple 
assumption does not hold for functional analyses. There is no evidence that important 
functional changes due to the disease process should be more clearly expressed than other 
ongoing cellular functions or effects of lifestyle. The search would be for genes that exerts a 
given time dependant pattern. The first analyses in systems epidemiology would be to sort 
the time-dependant functions of the 25 000 genes keeping in mind the consequences of the 
multiple testing. To sort out the highest p-values could remove very important information. 
Challenge four: The time-dependant analysis of the gene expression could need new 
statistical tests and adaption of new functions for the follow-up studies. A major task both of 
design, laboratory work and statistical methods would be to improve the sensitivity of the 
analyses. 
Challenge five: There is an obvious concern about the complexity of the total data structure 
of the functional information possible to obtain for a small number of cases and controls. 
This is a work that is ongoing in systems biology and several methods should be possible to 
adapt in order to improve the biological explanations of findings in the epidemiological 
studies. 
7. Discussion 
The design of a prospective study including trancriptomic options has only recently been 
implemented in the globolomic design of NOWAC. In the discussion of pro et cons for 
building new cohort studies the option for gene expression analyses are mostly neglected 
(19, 20, 21), but has been proposed by some (22). 
The notion of gene-expression as exposures confronts the epidemiologists with 
approximately 25 000 possibly time-dependant exposure variables. This adds to the well 
known uniqueness of each woman’s lifestyle. Consider data from the NOWAC study taking 
the mode of six well known factors that either increase or decrease the risk of breast cancer. 
Based on information from 172 000 women combining the mode value for age at menarche, 
parity, age at first full term pregnancy, age at menopause, age at first use of hormonal 
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replacement therapy and age at first use of oral contraceptive left no one to share the same 
lifetime exposure pattern. Even with so few variables the risk profiles of the women are 
highly different. It is under such conditions that the time dependant changes exert effects 
through the functioning of the genes. In order to focus on the overall importance of the 
exposures we would sum up over a person’s lifetime the continuously changing lifestyle 
with both risk and preventive factors. The diversity of exposures gives a diversity of 
functional changes and an individual may at the same time have several potential 
carcinogenic processes ongoing even within the same tissue “e.g” the effect of smoking and 
radiation exposure on lung tissue. 
It is well known that different exposures have different effect on the diseases. In cancer 
the carcinogenic process is different for exposures like radiation, chemicals, bacteria, and 
virus. In addition, several chemicals act as hormone imitators. There is no strong reason to 
believe in exact the same model of carcinogenesis for all exposures. Radiation hits the 
DNA in a different manner from use of hormones in postmenopausal women. 
Heterogeneity of exposures drives heterogeneity of functional changes and in the end the 
expression profiles.  
7.1 Trans-etiological research 
So far etiological or causal research has been done almost independently in basic cell biology 
and epidemiology except for the gene-environment analysis. One could call this a 
dichotomy, see Box 2.  
 Epidemiology basic genetic research 
Common approaches   
Gene-enviroment analyses                               exposure and gene interactions 
Bioinformatics                                gene functions 
   
Dualism   
Model of carcinogenesis multistage mutational 
Driving forces  exposures mutations 
   
Exposures  yes  mostly none 
   
Methods  observational  experimental 
Mechanistic/functional  no   yes, main focus 
Scientific approach  whole genome scan  
Time relationship  prospective cross-sectional 
   end-point related 
Causality  criteria for statistical association experimental verification 
  time order mRNA, oncogenes etc 
Time relationship   
Box 2. Examples of common approaches and the dualism between epidemiology and basic 
cancer research. 
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In almost every aspect of scientific work these two disciplines have different views, 
methods and models. The expansion of functional genomics into epidemiology could 
improve the communications far beyond the current. While methodologies and designs of 
studies differ greatly, this could be considered as a natural consequence of the research 
fields. But behind this is the deeper conflict in science between those used to put up 
deductive hypothesis and test them in experiments versus the agnostic approach to the 
observational studies in epidemiology. The history of genomic analysis, SNPs, going from 
single gene studies over annotated genes till pathways analyses and ending up in GWAS 
clearly demonstrates the very different approaches scientifically in basic genetic research 
and epidemiology – from deductive designs of experiments till observational studies 
searching for associations. In order to improve collaboration between basic genetic 
research and epidemiology mutual understanding of methodological approaches in each 
discipline would be important. 
8. Concluding remarks 
A unique opportunity to expand design and interpretations of statistical associations in 
epidemiological studies has been given due to new technologies. At the same time this 
opportunity will depend on a closer collaboration between basic researchers in different 
biological disciplines and epidemiologist, giving us a possibility of a new trans-etiological 
research. 
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